Home
Scholarly Works
MA 10.01 Durvalumab ± Tremelimumab with...
Conference

MA 10.01 Durvalumab ± Tremelimumab with Platinum-Doublets in Non-Small Cell Lung Cancer: Canadian Cancer Trials Group Study IND.226

Authors

Juergens R; Hao D; Laurie S; Ellis P; Mates M; Bradbury P; Tehfe M; Kollmannsberger C; Arnold A; Goffin J

Volume

12

Publisher

Elsevier

Publication Date

November 1, 2017

DOI

10.1016/j.jtho.2017.09.533

Conference proceedings

Journal of Thoracic Oncology

Issue

11

ISSN

1556-0864

Contact the Experts team